SCHEMBL8220992

SCHEMBL8220992

CCCCOC[C@H]1C[C@@H](CN2CCOCC2)C1(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.40
MAPK1 P28482 3/20 0.40
CYP1A2 P05177 1/20 0.40
CHRM2 P08172 1/20 0.40
CHRM1 P11229 1/20 0.40
HTR2A P28223 1/20 0.40
SCN1A P35498 1/20 0.40
HTR2B P41595 1/20 0.40
KCNH2 Q12809 1/20 0.40
SCN2A Q99250 1/20 0.40
SIGMAR1 Q99720 1/20 0.40
SCN3A Q9NY46 1/20 0.40
HRH3 Q9Y5N1 1/20 0.40
LMNA P02545 4/20 0.39
USP2 O75604 2/20 0.39
SMN1; SMN2 Q16637 4/20 0.37
PDK1 Q15118 1/20 0.36
POLB P06746 1/20 0.35
TSHR P16473 2/20 0.34
KMT2A Q03164 4/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13415946 0.87 ALDH1A1 (0.44) ALDH1A1MAPK1CYP1A2CHRM2CHRM1
SCHEMBL8219690 0.86 ALDH1A1 (0.36) ALDH1A1CYP1A2CHRM2HTR2AKCNH2
SCHEMBL8217438 0.85 SMN1; SMN2 (0.35) ALDH1A1SMN1; SMN2PDK1THRBTDP1
SCHEMBL8213467 0.79 DRD2 (0.44) ALDH1A1HTR2AKCNH2SIGMAR1HRH3
SCHEMBL8219694 0.77 DRD2 (0.48) CYP1A2SIGMAR1TSHRKMT2AMEN1
SCHEMBL3315455 0.74 POLB (0.39) ALDH1A1SIGMAR1LMNASMN1; SMN2POLB
SCHEMBL13415964 0.73 NPC1 (0.34) HRH3SMN1; SMN2THRBTHRANPC1
SCHEMBL13415993 0.73 NPC1 (0.34) HRH3SMN1; SMN2THRBTHRANPC1
SCHEMBL13416003 0.73 LTA4H (0.37) ALDH1A1CYP1A2CHRM2HTR2AKCNH2
Alcohol SCHEMBL3313269 0.71 KDM4E (0.36) ALDH1A1MAPK1LMNAUSP2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2066648-B1 SUBSTITUTED DIMETHYLCYCLOBUTYL COMPOUNDS, THEIR PREPARATION AND USE IN MEDICAMENTS ESTEVE LABOR DR (ES) 2017-04-12 EP disclosed
US-20100105680-A1 SUBSTITUTED DIMETHYLCYCLOBUTYL COMPOUNDS, THEIR PREPARATION AND USE IN MEDICAMENTS LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2010-04-29 US disclosed
WO-2008015266-A1 SUBSTITUTED DIMETHYLCYCLOBUTYL COMPOUNDS, THEIR PREPARATION AND USE IN MEDICAMENTS LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2008-02-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100105680-A1 SUBSTITUTED DIMETHYLCYCLOBUTYL COMPOUNDS, THEIR PREPARATION AND USE IN MEDICAMENTS SIGMAR1, TMEM97, OPRK1 ALDH1A1 1719/4885MAPK1 1218/4885CYP1A2 104/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.